linkedin

Most Innovative,
Flexible and
Cost-effective Plant

PLANT 3
- The Most Competitive Plant
  • Maximum Scale
    (DS 180,000L)
  • Total Capacity
    180,000L (12x15,000L)
  • Construction
    35 months to cGMP ready
  • 2021
    2021 2021
    • SEP.

      Launch of the CDO process platform, S-Cellerate™

    • MAY.

      Manufacturing Partnership with Moderna
      for its COVID-19 vaccine

      Global ISO Certifications for BCMS, Energy,
      Health & Safety, and Environmental Management

    • APR.

      10th Anniversary

  • 2020
    2020 2020
      • NOV.

        Manufacturing Partnership with Eli Lilly for its COVID-19 antibody treatment

        Groundbreaking of Plant 4, the “Super Plant”

      • OCT.

        Opening of the San Francisco R&D Center

      • SEP.

        Manufacturing Partnership with AstraZeneca

      • AUG.

        Launch of proprietary cell line development platform,
        S-CHOice™

      • JUN.

        Opening of Virtual Exhibition Hall

      • MAY.

        ISO22301 Certification

        Expanded Manufacturing Partnership with GSK

      • APR.

        Manufacturing Partnership with Vir for its COVID-19 treatment

  • 2019
    2019 2019
    • NOV.

      ISO 27001 Certification

    • APR.

      Manufacturing Partnership with CytoDyn

  • 2018
    2018 2018
    • OCT.

      AEO (Authorized Economic Operator) Certification

      Plant 3 cGMP Ready

    • JUL.

      Manufacturing Partnership with UCB

    • APR.

      ISO 22301 Certification (BCMS, Business Continuity Management System)

  • 2017
    2017 2017
    • DEC.

      First Approval of Plant 2 by EMA

    • NOV.

      Plant 3 Mechanical Completion

    • OCT.

      MOU for Strategic Alliance with Merck (MSD)

    • SEP.

      First Approval of Plant 2 by FDA

    • JUL.

      Manufacturing Partnership with Sun Pharma

    • MAY.

      First Approval of Plant 1 by PMDA

Samsung’s
Innovative Design

PLANT 2
- The Largest Single Plant
  • 5X Scale
    (DS 150,000L + DP Fill/Finish)
  • Total Capacity - 154,000L
    (10x15,000L / 4x1,000L)
  • Construction - 29 months
    to cGMP ready
  • 2016
    2016 2016
    • NOV.

      Samsung Biologics IPO on KOSPI

    • JUL.

      First Approval of Plant 1 by EMA

    • FEB.

      Plant 2 DS cGMP Ready

  • 2015
    2015 2015
    • NOV.

      First Approval of Plant 1 by FDA

      Plant 3 Construction Started

    • FEB.

      Plant 2 Mechanical Completion

  • 2014
    2014 2014
    • APR.

      DP Manufacturing Partnership with BMS

Standard Design

PLANT 1
- Industry Standard
  • Industry Average Scale
    (DS 30,000L + DP Fill/Finish)
  • Total Capacity - 30,000L
    (6x5,000L)
  • Construction - 25 months
    to cGMP ready
  • 2013
    2013 2013
    • OCT.

      Manufacturing Partnership with Roche

    • SEP.

      Plant 2 Construction Started

    • AUG.

      Plant 1 DP cGMP Ready

    • JUL.

      Manufacturing Partnership with BMS

    • JUN.

      Plant 1 DS cGMP Ready

  • 2012
    2012 2012
    • JUL.

      Plant 1 Mechanical Completion

  • 2011
    2011 2011
    • MAY.

      Plant 1 Construction Started

    • APR.

      Foundation of Samsung Biologics

SITE MAP

close
Close

Thank you for Subscribing to Our Newsletter

아래 다운로드 버튼을 클릭하시면 바로 다운로드 하실 수 있습니다.

Close

Subscribe to Our Newsletter

파일 다운로드를 위해 뉴스레터 구독용 이메일 주소를 입력해주세요.
* 구독자라면 구독중인 이메일 주소를 입력해주세요.

뉴스레터 구독 서비스 유무 확인
Close

Subscribe to Our Newsletter

뉴스레터 구독 서비스를 등록하시면 당사 뉴스룸에서 제공되는
삼성바이오로직스의 최신 소식과 관심 분야별 유용한 정보를 받아 보실 수 있습니다.

Subscribe to Our Newsletter
    • - 개인정보 수집 목적 : 이메일 발신서비스 제공
    • - 개인정보 수집 항목 : 이메일 주소, 회사명, 이름, 직급, 국가
    • - 이용 및 보관 기간 : 이메일 발신서비스 해지 시까지

    개인정보 수집에 동의하지 않을 시, 뉴스레터 서비스를 이용할 수 없습니다.

    삼성바이오로직스 개인정보 보호정책에 따라 개인정보는 안전하게 관리됩니다.

close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION

Copyright Samsung Biologics. All rights reserved